The votes are nonbinding, but they amount to a rebuke of the FDA’s own scientists who said the drugs have not been studied enough to know whether they are safe or effective.

Emergency presentation (EP) for cancer diagnosis is common among older US adults and predicts persistently elevated mortality, according to a study published online July 14 in the Journal of the ...

Credit: mannKind. Furoscix ReadyFlow offers a rapid, outpatient alternative for acute fluid overload management in heart failure and chronic kidney disease. Furoscix ReadyFlow demonstrated a ...

Kalshi starts prediction market for clinical trials and FDA approvals; positive results shared for triple hormone receptor agonist therapy retatrutide; Jideytro gains approval in advanced or ...

These findings can guide development of AGS surveillance systems and help identify regions with increased risk. HealthDay News — The estimated seroprevalence of alpha-gal immunoglobulin E (IgE) ...

The oral RAS(ON) multi-selective inhibitor nearly doubled overall survival compared with investigator’s choice chemotherapy in the phase 3 RASolute 302 trial.

Retatrutide 12mg achieved up to 22.6% (55.8 lbs) mean weight loss at week 80, alongside marked improvements in ...

Lundbeck’s investigational oral orexin 2 receptor agonist gains Fast Track status, aiming to address underlying pathophysiology in patients with narcolepsy.

The analysis included 75 brick-and-mortar weight-loss clinics and medical spas offering compounded GLP-1 RAs. HealthDay News — Despite the end of nationwide shortages of glucagon-like peptide-1 ...

One in about 7300 individuals in the general population have PMS, a rare genetic condition that causes medical, intellectual, and behavioral challenges.

In a scientific statement, the association states that consuming caffeinated coffee linked to reduced risks for type 2 diabetes, heart disease, stroke, heart failure.